$4.00
-0.13-3.15%
Last update: Oct 23, 5:59 PM
Aquestive Therapeutics Inc (AQST) Stock Price, Quote, News & History
AQSTNASDAQ
Eton Pharmaceuticals licenses Aquestive’s LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.
You can purchase shares of Aquestive Therapeutics (NASDAQ:AQST) through any online brokerage.
Other companies in Aquestive Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Aquestive Therapeutics has a consensus price target of $9.90.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $4 last updated October 23, 2026 at 5:59 PM EDT.
There are no upcoming dividends for Aquestive Therapeutics.
Aquestive Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous...
